These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37540905)

  • 1. Hormone sensitivity predicts the beneficial effects of transdermal estradiol on reward-seeking behaviors in perimenopausal women: A randomized controlled trial.
    Swales DA; Lozza-Fiacco S; Andersen EH; Cooper JA; Treadway MT; Xia K; Schiller CE; Girdler SS; Dichter GS
    Psychoneuroendocrinology; 2023 Oct; 156():106339. PubMed ID: 37540905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline anxiety-sensitivity to estradiol fluctuations predicts anxiety symptom response to transdermal estradiol treatment in perimenopausal women - A randomized clinical trial.
    Lozza-Fiacco S; Gordon JL; Andersen EH; Kozik RG; Neely O; Schiller C; Munoz M; Rubinow DR; Girdler SS
    Psychoneuroendocrinology; 2022 Sep; 143():105851. PubMed ID: 35809362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perimenopausal Effects of Estradiol on Anhedonia and Psychosis Study (PEEPs): study protocol for a neural and molecular mechanistic clinical trial.
    Walsh MJM; Gibson K; Hynd M; Eisenlohr-Moul TA; Walsh EC; Schiff L; Jarskog F; Lalush D; Dichter GS; Schiller CE
    Trials; 2023 Feb; 24(1):150. PubMed ID: 36855177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and psychosocial moderators of mindfulness-based stress reduction for the prevention of perimenopausal depressive symptoms: A randomized controlled trial.
    Gordon JL; Halleran M; Beshai S; Eisenlohr-Moul TA; Frederick J; Campbell TS
    Psychoneuroendocrinology; 2021 Aug; 130():105277. PubMed ID: 34058560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
    Schmidt PJ; Ben Dor R; Martinez PE; Guerrieri GM; Harsh VL; Thompson K; Koziol DE; Nieman LK; Rubinow DR
    JAMA Psychiatry; 2015 Jul; 72(7):714-26. PubMed ID: 26018333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood sensitivity to estradiol predicts depressive symptoms in the menopause transition.
    Gordon JL; Sander B; Eisenlohr-Moul TA; Sykes Tottenham L
    Psychol Med; 2021 Jul; 51(10):1733-1741. PubMed ID: 32156321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms.
    Joffe H; de Wit A; Coborn J; Crawford S; Freeman M; Wiley A; Athappilly G; Kim S; Sullivan KA; Cohen LS; Hall JE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e642-50. PubMed ID: 31693131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression.
    Karaoulanis SE; Rizouli KA; Rizoulis AA; Angelopoulos NV
    BMC Psychiatry; 2014 Jun; 14():164. PubMed ID: 24894416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally Occurring Changes in Estradiol Concentrations in the Menopause Transition Predict Morning Cortisol and Negative Mood in Perimenopausal Depression.
    Gordon JL; Eisenlohr-Moul TA; Rubinow DR; Schrubbe L; Girdler SS
    Clin Psychol Sci; 2016 Sep; 4(5):919-935. PubMed ID: 27867758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and Follicle-Stimulating Hormone as Predictors of Onset of Menopause Transition-Related Bone Loss in Pre- and Perimenopausal Women.
    Shieh A; Greendale GA; Cauley JA; Karvonen-Gutierrez C; Crandall CJ; Karlamangla AS
    J Bone Miner Res; 2019 Dec; 34(12):2246-2253. PubMed ID: 31442329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
    Soares CN; Almeida OP; Joffe H; Cohen LS
    Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: A hypothesis paper.
    Gordon JL; Sander B
    Psychoneuroendocrinology; 2021 Nov; 133():105418. PubMed ID: 34607269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Leserman J; Girdler SS
    Menopause; 2016 Mar; 23(3):257-66. PubMed ID: 26529616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of irritability symptoms in mildly depressed perimenopausal women.
    de Wit AE; Giltay EJ; de Boer MK; Nathan M; Wiley A; Crawford S; Joffe H
    Psychoneuroendocrinology; 2021 Apr; 126():105128. PubMed ID: 33493755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
    Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression.
    Schmidt PJ; Wei SM; Martinez PE; Dor RRB; Guerrieri GM; Palladino PP; Harsh VL; Li HJ; Wakim P; Nieman LK; Rubinow DR
    Menopause; 2021 Jan; 28(4):369-383. PubMed ID: 33470755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
    Gordon JL; Rubinow DR; Watkins L; Hinderliter AL; Caughey MC; Girdler SS
    J Clin Endocrinol Metab; 2020 May; 105(5):e2050-60. PubMed ID: 31838497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsychosocial factors intersecting with weekly sleep difficulties in the menopause transition.
    Chenji S; Sander B; Grummisch JA; Gordon JL
    Maturitas; 2024 Nov; 189():108111. PubMed ID: 39241486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.